Form 4: CVS Health Executive J. David Joyner Reports Stock Transaction

J. David Joyner, EVP & President of Pharmacy Services at CVS Health, reported a transaction involving the surrender of shares to cover withholding taxes upon vesting of a restricted stock award on February 28, 2024.

Summary

• On February 28, 2024, J. David Joyner, an Executive Vice President and President of Pharmacy Services at CVS Health, reported a transaction.
• The transaction involved the surrender of 1,970 shares of common stock at a price of $75.19 per share.
• This was done to cover withholding taxes due upon the vesting of a restricted stock award.
• Following the transaction, Joyner directly owns 40,681 shares of common stock and 15,961 shares of restricted common stock.
• Joyner also holds options to purchase 51,959 shares of common stock, which become exercisable in four equal annual installments starting April 1, 2024.

Sentiment

Score: 5

Explanation: This is a neutral event, reflecting a standard transaction related to executive compensation and tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies like CVS Health. These filings are monitored by investors for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it is a routine adjustment of an executive's holdings.

Key Dates